Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
September 24, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, Sept. 24, 2024 (GLOBE NEWSWIRE) -- Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight ...
Claritas HealthTech Furthers its Capabilities in Urology with ReDisys™, a Computer Aided Detection Software for Kidney Cancer in CT Scans
September 01, 2024 23:00 ET
|
Claritas HealthTech Ltd
Claritas HealthTech Furthers its Capabilities in Urology with ReDisys™, a Computer Aided Detection Software for Kidney Cancer in CT Scans
First US Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product
January 24, 2021 17:55 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and INDIANAPOLIS, Jan. 24, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that the first patients have been dosed in...
Telix Pharmaceuticals and China Grand Pharma Announce Strategic Licence and Commercial Partnership for Greater China Market
November 01, 2020 23:11 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and HONG KONG, Nov. 02, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) announces it has entered into a strategic licence and...
First Patients Dosed in Phase III ZIRCON Trial of Renal Cancer Imaging Product in Turkey
October 22, 2020 01:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and ISTANBUL, Turkey, Oct. 22, 2020 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) and Eczacıbaşı-Monrol Nuclear Products Co. (‘Eczacıbaşı...
Telixが日本で腎臓がん用画像診断薬の臨床治験を開始
August 29, 2019 20:00 ET
|
Telix Pharmaceuticals Limited
メルボルン, オーストラリア および京都, 日本, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals...
Telix Pharmaceuticals to Launch Japanese Renal Cancer Imaging Study
August 29, 2019 20:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Aug. 30, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the...
テリックスと日本メジフィジックスが アクチニウム標識腎癌治療薬の開発を目指した技術提携契約を締結
November 28, 2018 18:17 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited（本社：オーストラリア メルボルン、CEO：Dr. Christian...
Telix and Nihon Medi-Physics to Collaborate on Actinium Renal Cancer Therapeutics
November 28, 2018 18:17 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, KYOTO, Japan and TOKYO, Nov. 29, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused...
Telix and Cyclotek Enter into Manufacturing Partnership for Kidney Cancer Imaging
October 14, 2018 18:00 ET
|
Telix Pharmaceuticals Limited
MELBOURNE, Australia, Oct. 15, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of...